Apr 24, 2017 - With Biogen (BIIB) set to report Q1 results tomorrow, here is a look at 3 key factors investors will be focused on apart from earnings and revenue.
Apr 21, 2017 - NewLink Genetics intriguing IDO-inhibitors could make it a target of Gilead Sciences.
Apr 21, 2017 - Merck may be a picture-perfect stock for long-term investors to consider buying.
Apr 20, 2017 - The Zacks Analyst Blog Highlights: Berkshire Hathaway, Oracle, Merck, Honeywell and Altria
Apr 19, 2017 - Top Research Reports for Today: BRK.B, ORCL, MRK
Apr 19, 2017 - Johnson & Johnson (JNJ) reported mixed first-quarter 2017 earnings results on Tuesday.
Apr 19, 2017 - Does Merck's sizzling-hot cancer drug Keytruda give it a leg up over longtime winner Johnson & Johnson?
Apr 18, 2017 - Roche Holding AG's (RHHBY) unit, Genentech, announced that its drug Tecentriq (atezolizumab) has received FDA approval on an accelerated basis for initial treatment of people with advanced urothelial carcinoma (mUC).
Apr 18, 2017 - Johnson & Johnson (JNJ) reported mixed first quarter results, with earnings beating expectations while sales missing the same.
Apr 17, 2017 - Zoetis Inc. (ZTS) announced an agreement to buy Nexvet Biopharma plc (NVET) for an aggregate equity valuation of approximately $85 million